本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Summit Therapeutics PLC

26.20
-1.4300-5.18%
盘后26.400.2000+0.76%19:58 EDT
成交量:301.07万
成交额:8,050.20万
市值:194.58亿
市盈率:-77.16
高:28.13
开:27.91
低:26.05
收:27.63
数据加载中...
2020/02/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超过5%披露

General statement of acquisition of beneficial ownership
2020/01/16

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/27

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露报告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

SEC问询函

[Cover]Correspondence
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]